Diets
ketogenic diet causes gastrointestinal and induction adverse effects
In plain terms: Does starting the ketogenic diet commonly cause side effects like constipation, nausea and fatigue?
Strong support Diets 💰 Industry COI noted🔬 Includes disconfirming
Part of: 🥗 ketogenic diet
RefutedContestedStrong support
consensus score 0.80
Yes — the "keto flu" is real: constipation, nausea, vomiting and lethargy are commonly reported on initiation, usually mild and manageable but genuine.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
8 support 1 contradict 0 tested null 2 mixed · 11 sources, 9 independent groups
The evidence (16)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Sáenz de Pipaón 2020 · Front Nutr | observational | supports | low | Commentary on consumer reports characterized \"keto flu\" (fatigue, nausea, headache, GI upset) as a common early-phase phenomenon on the ketogenic diet. |
| Hu W et al 2025 · Front Neurol | observational | supports | moderate | Prospective non-randomised cohort, add-on 4:1 KD (n=128) vs ASM-adjustment (n=140) in pediatric DEE, 6-month follow-up. Adverse events reported for the KD arm ONLY (no control AE rate given): 'A total of 45 patients (35.16%) in KD group experience adverse reactions. Among them, 41 (32.03%) patients had gastrointestinal reactions, including 20 (15.63%) of vomiting, 12 (9.38%) of diarrhea, and 9 (7.03%) of constipation... Only 4 children (3.13%) discontinued KD treatment, of which 3 cases (2.34%) because of hyperuricemia and 1 case (0.78%) because of urinary calculi. All observed adverse events occurred during the first 3 months of KD treatment.' Authors add that 'approximately one-third of children developed gastrointestinal symptoms in the early stage of add-on KD treatment.' Their 'slight and tolerable' verdict is about SEVERITY, not occurrence. Caveats: AEs 'evaluated based on parental observations and descriptions'; 18 KD patients lasting <6 months were excluded from the 128 denominator, biasing early-AE incidence downward; authors state the sample 'limits the statistical power ... for detecting less common adverse effects'. |
| Rieger 2014 · Int J Oncol | observational | mixed | low | ERGO pilot found the ketogenic diet feasible with three of 20 patients discontinuing for poor tolerability, indicating meaningful but not universal adverse effects. |
| Rolley C et al 2026 · study_type: observational | observational | supports | low | Single-arm KD pilot in mRCC (n=21): diarrhea 55%, weight loss 45%, hypercholesterolemia 40%, dyspepsia 30%, no severe events; only 40% completed 12mo. |
| Matairi AA et al 2025 · World J Pediatr | meta-analysis | supports | low | Same meta-analysis; safety was a secondary outcome ('the secondary outcomes included cognitive function, quality of life, and adverse events'). The prior extract said only that adverse effects were 'catalogued' and carried no figure at all. The KD-specific, ON-OBJECT (gastrointestinal) result is diarrhea: 'Adverse events varied: constipation was most common with MAD (30.97%), whereas KD had higher rates of respiratory infections (42.77%, P < 0.0001 vs. MAD) and diarrhea (13.75% vs. 8.11%, P = 0.0017).' READ THE ATTRIBUTIONS: the 30.97% constipation rate is the MODIFIED ATKINS arm's, not the ketogenic diet's, and must not be carried here as a KD figure; the 42.77% respiratory-infection rate IS the ketogenic diet's but is neither a gastrointestinal nor an induction effect, so it is recorded as a candidate finding rather than as support on this object. This source's entire contribution to this claim is therefore one pooled KD diarrhea rate of 13.75%, significantly above the comparator diet's 8.11% (P = 0.0017). DENOMINATOR: the abstract gives no participant count behind 13.75% - no total n, no KD-arm n, and no study count for the safety pooling appears anywhere in it - cannot-tell from available text. Stance supports STANDS (a measured GI adverse-event rate on the ketogenic diet), but on one symptom, not the catalogue the prior extract implied. QUALITY moderate -> low on the paper's own reliability statements: 'Heterogeneity was substantial in most analyses (I2 > 75%)'; randomised and non-randomised designs are pooled together ('Eligible studies were randomized controlled trials and prospective cohort studies') and appraised with a randomised-trials-only instrument ('The risk of bias was assessed via the Cochrane Risk of Bias 2 tool'). Abstract-only (no PMCID). Declared COI: 'The authors have no conflict of interest to declare.' |
| Schopf C et al 2026 · study_type: meta-analysis | meta-analysis | supports | moderate | Systematic review, 36 studies/42 KD interventions: 43% of participants had ≥1 AE (0.91±0.71/person); GI 40%, neurological 17%, metabolic 12%; constipation 24% most common. |
| Firdous 2026 · Neurol Sci | meta-analysis | supports | moderate | Systematic review in glioblastoma found the ketogenic diet generally well tolerated with adverse events limited to mild GI symptoms and fatigue, tempering claims that induction effects are severe or universal. |
| Skartun 2025 · Front Nutr | observational | supports | moderate | Scoping review documented that keto-induction commonly triggers transient \"keto-flu\" symptoms including fatigue, nausea, headache, and GI disturbance, and catalogued relief strategies. |
| Dynka D, et al. 2026 · Ann Med | observational | supports | low | Review of ketogenic-diet safety reported commonly observed adverse effects including constipation, nausea, fatigue, and headache, especially during initiation. |
| Feil K et al 2025 · study_type: observational | observational | supports | low | ICU SOP for classical KD in status epilepticus: flags metabolic acidosis, hypoglycemia, hyperlipidemia as known AEs requiring monitoring/timely adjustment. |
| Schreck 2021 · Neurology | observational | mixed | moderate | Feasibility trial of a ketogenic/intermittent-fasting diet in glioma found it safe and tolerable, with adverse effects generally mild. |
| Emanuele 2025 · Nutrients | observational | supports | moderate | Review of ketogenic diets in steatotic liver disease noted transient keto-flu symptoms and GI disturbances requiring clinical monitoring. |
| Ray S, Nathan J, Godhia M 2024 · Epilepsy Res | observational | supports | moderate | Tolerability endpoints of a two-arm ketogenic-diet trial in 52 children aged 2-10 with refractory epilepsy: 'Tolerability was assessed and compared by recording adverse events - vomiting, nausea, lethargy, and constipation.' Both arms received a ketogenic diet ('Fat: carbohydrate + protein ratio of 2.2:1-4:1 was maintained in both diets'), so there is no randomised keto-vs-no-keto contrast for harms; graded observational, not RCT, on the exposure-randomised test. The only reported adverse-event result is BETWEEN the two keto variants: 'Nausea (p=0.033) and vomiting (p=0.014) occurred more in PUFAKD than in CKD.' DENOMINATORS: 25 CKD and 27 PUFAKD. ABSOLUTE INCIDENCE of any adverse event is not reported in the abstract - only p-values - and lethargy and constipation are named as endpoints with no figure attached. Supports the claim only in that these GI/induction events occurred on ketogenic diets and were frequent enough to differ significantly between two keto formulations; it cannot quantify keto-attributable incidence. Abstract-only (Elsevier paywall). |
| Muensterman E et al 2025 · study_type: observational | observational | contradicts | low | Real-world ADPKD KD program (n=103, 3mo, single-arm): eGFR improved, headaches and kidney pain decreased, safety markers (lipids/electrolytes/acid-base) stable throughout. |
| Nassar 2024 · Sci Rep | observational | supports | moderate | Clinical trial in children on KD documented slowed gastric emptying, constipation and GI symptoms as characteristic adverse effects, mitigated by L-carnitine supplementation. |
| Chylińska N et al 2025 · study_type: observational | observational | supports | low | Narrative review of KD effects on skin (acne, psoriasis, HS, melanoma); explicitly catalogs 'reported adverse effects of KD on the skin' alongside mechanisms. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.